Pulse Biosciences, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Pulse Biosciences, Inc. (PLSE) had Deferred Tax Assets, Operating Loss Carryforwards of $74.86 million as of 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-02-19
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $74.86M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $66.95M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $61.07M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $56.45M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $74.86M 10-K · filed 2026-02-19 |
| 2024-12-31 | $66.95M 10-K · filed 2026-02-19 |
| 2023-12-31 | $61.07M 10-K · filed 2025-03-31 |
| 2022-12-31 | $56.45M 10-K · filed 2024-03-28 |
| 2021-12-31 | $49.25M 10-K · filed 2023-03-31 |
| 2020-12-31 | $36.53M 10-K · filed 2022-03-31 |
| 2019-12-31 | $20.75M 10-K · filed 2021-03-12 |
| 2018-12-31 | $15.37M 10-K · filed 2020-03-16 |
| 2017-12-31 | $7.71M 10-K · filed 2019-03-14 |
| 2016-12-31 | $5.12M 10-K · filed 2018-03-16 |
| 2015-12-31 | $1.59M 10-K · filed 2017-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |